{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:50:01Z","timestamp":1789213801589,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":599,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jacc.2011.07.051","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T16:38:10Z","timestamp":1324312690000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Cardiac Uses of Phosphodiesterase-5 Inhibitors"],"prefix":"10.1016","volume":"59","author":[{"given":"Bryan G.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Comstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera J.","family":"Stecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.07.051_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCULATIONAHA.110.944603","article-title":"Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJMct0904473","article-title":"Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension","volume":"361","author":"Archer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.CIR.0000027149.83473.B6","article-title":"Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction","volume":"106","author":"Bocchi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib5","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.amjcard.2005.06.091","article-title":"Effect of sildenafil on cardiac performance in patients with heart failure","volume":"96","author":"Hirata","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archinte.164.5.514","article-title":"Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial","volume":"164","author":"Webster","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cardfail.2007.11.006","article-title":"Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial","volume":"14","author":"Behling","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2011.07.051_bib8","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","article-title":"Long-term use of sildenafil in the therapeutic management of heart failure","volume":"50","author":"Guazzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacc.2009.05.021","article-title":"Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil","volume":"54","author":"Melenovsky","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.109.906818","article-title":"Oxidative stress regulates left ventricular PDE5 expression in the failing heart","volume":"121","author":"Lu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility","volume":"116","author":"Nagendran","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib12","doi-asserted-by":"crossref","first-page":"H2272","DOI":"10.1152\/ajpheart.00654.2010","article-title":"Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA\/Rho-kinase pathway","volume":"300","author":"Chau","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib13","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2010.08.612","article-title":"Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5","volume":"56","author":"Zhang","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","article-title":"Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/01.CIR.0000160359.49478.C2","article-title":"Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity","volume":"111","author":"Fisher","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.110.170191","article-title":"Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect","volume":"334","author":"Koka","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2011.07.051_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.vph.2005.02.010","article-title":"Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications","volume":"42","author":"Kukreja","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacc.2011.07.051_bib19","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.ajpheart.91438.2007","article-title":"Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice","volume":"294","author":"Salloum","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10557-005-5203-4","article-title":"Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin","volume":"20","author":"Rosanio","year":"2006","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2011.07.051_bib21","doi-asserted-by":"crossref","first-page":"H1263","DOI":"10.1152\/ajpheart.00324.2002","article-title":"Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits","volume":"283","author":"Ockaili","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yjmcc.2007.10.006","article-title":"Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection","volume":"44","author":"Wang","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib23","doi-asserted-by":"crossref","first-page":"H387","DOI":"10.1152\/ajpheart.00169.2009","article-title":"Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury","volume":"297","author":"Ahmad","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yjmcc.2005.10.002","article-title":"Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia\/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits","volume":"40","author":"Salloum","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/FJC.0b013e318157fd5b","article-title":"Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection","volume":"50","author":"Jamnicki-Abegg","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2011.07.051_bib26","doi-asserted-by":"crossref","first-page":"H827","DOI":"10.1152\/ajpheart.00129.2010","article-title":"Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury","volume":"299","author":"Madhani","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2011.07.051_bib27","first-page":"S31","article-title":"Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia\/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide","volume":"120","author":"Salloum","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.ijir.3901497","article-title":"The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size","volume":"19","author":"Sesti","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.jacc.2011.07.051_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejcts.2009.03.065","article-title":"Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass","volume":"36","author":"Szabo","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2011.07.051_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0008-6363(03)00435-8","article-title":"Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation","volume":"59","author":"Reffelmann","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2011.07.051_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1464-410X.2006.06019.x","article-title":"Phosphodiesterase-5 inhibitors help climbers to achieve new heights","volume":"97","author":"Swallow","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.jacc.2011.07.051_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14656566.9.1.119","article-title":"High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema","volume":"9","author":"Wright","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacc.2011.07.051_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1183\/09059180.00011104","article-title":"High-altitude pulmonary hypertension","volume":"18","author":"Xu","year":"2009","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jacc.2011.07.051_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-145-7-200610030-00007","article-title":"Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial","volume":"145","author":"Maggiorini","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1164\/rccm.200808-1348OC","article-title":"Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema","volume":"180","author":"Fischler","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/hc2901.093117","article-title":"Sildenafil inhibits hypoxia-induced pulmonary hypertension","volume":"104","author":"Zhao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib37","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1152\/japplphysiol.00806.2005","article-title":"Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia","volume":"100","author":"Hsu","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-141-3-200408030-00005","article-title":"Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial","volume":"141","author":"Ghofrani","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thx.2005.041954","article-title":"Phosphodiesterase type 5 and high altitude pulmonary hypertension","volume":"60","author":"Aldashev","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.jacc.2011.07.051_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00395-004-0504-5","article-title":"Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells","volume":"100","author":"Tantini","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.HYP.0000239816.13007.c9","article-title":"Effect of regular phosphodiesterase type 5 inhibition in hypertension","volume":"48","author":"Oliver","year":"2006","journal-title":"Hypertension"},{"issue":"Suppl","key":"10.1016\/j.jacc.2011.07.051_bib42","doi-asserted-by":"crossref","first-page":"13C","DOI":"10.1016\/S0002-9149(99)00043-0","article-title":"Effects of sildenafil citrate on human hemodynamics","volume":"83","author":"Jackson","year":"1999","journal-title":"Am J Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2011.07.051_bib43","doi-asserted-by":"crossref","first-page":"37M","DOI":"10.1016\/S0002-9149(03)00074-2","article-title":"Cardiovascular effects of tadalafil","volume":"92","author":"Kloner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.07.051_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.109.147686","article-title":"Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension","volume":"56","author":"Oliver","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2011.07.051_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.166.2.231","article-title":"Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease","volume":"166","author":"Caglayan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2011.07.051_bib46","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.051_bib47","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116475","article-title":"Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study","volume":"69","author":"Brueckner","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2011.07.051_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.clpt.6100103","article-title":"The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon","volume":"81","author":"Friedman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2011.07.051_bib49","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3899\/jrheum.090270","article-title":"Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis","volume":"36","author":"Schiopu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jacc.2011.07.051_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.30195","article-title":"Modified-release sildenafil reduces Raynaud's attack frequency in limited cutaneous systemic sclerosis","volume":"63","author":"Herrick","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2011.07.051_bib51","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.mehy.2004.03.042","article-title":"Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia","volume":"63","author":"Downing","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jacc.2011.07.051_bib52","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1378\/chest.128.4.3065","article-title":"The potential use of type-5 phosphodiesterase inhibitors in coronary artery bypass graft surgery","volume":"128","author":"Fung","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2011.07.051_bib53","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/ATVBAHA.107.147421","article-title":"Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway","volume":"27","author":"Senthilkumar","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.051_bib54","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/ATVBAHA.109.201327","article-title":"A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1\/vascular endothelial growth factor pathway","volume":"30","author":"Sahara","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971104527X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971104527X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:49:27Z","timestamp":1760014167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971104527X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S073510971104527X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.07.051","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718008061.793476175","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Uses of Phosphodiesterase-5 Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}